4//SEC Filing
Sawicki Mark W 4
Accession 0001104659-23-031940
CIK 0001124524other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 9:24 PM ET
Size
9.1 KB
Accession
0001104659-23-031940
Insider Transaction Report
Form 4
Cryoport, Inc.CYRX
Sawicki Mark W
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-03-13$20.14/sh−1,476$29,727→ 63,032 total - Exercise/Conversion
Restricted Stock Rights
2023-03-09−2,667→ 5,333 total→ Common Stock (2,667 underlying) - Exercise/Conversion
Common Stock
2023-03-09+2,667→ 64,508 total
Footnotes (3)
- [F1]Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock.
- [F2]Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights.
- [F3]The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023.
Documents
Issuer
Cryoport, Inc.
CIK 0001124524
Entity typeother
Related Parties
1- filerCIK 0001848218
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 9:24 PM ET
- Size
- 9.1 KB